Clinical Trial Update: A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®

View source ↗

Summary

A six-month non-interventional trial update assessing rescue medication use and quality of life in adults with asthma treated with Symbicort SMART.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED